KR927003520A - 펩티딜(peptidyl) 유도체 - Google Patents
펩티딜(peptidyl) 유도체 Download PDFInfo
- Publication number
- KR927003520A KR927003520A KR1019920701787A KR920701787A KR927003520A KR 927003520 A KR927003520 A KR 927003520A KR 1019920701787 A KR1019920701787 A KR 1019920701787A KR 920701787 A KR920701787 A KR 920701787A KR 927003520 A KR927003520 A KR 927003520A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- alkyl
- amino
- compound
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
내용 없음
Description
펩티딜(peptidyl) 유도체
[도면의 간단한 설명]
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (8)
- 식(I)의 화합물과 이의 염, 용매화합물 및 수화물,여기서 R은 -CONHOH, 카르복실(-CO2H) 또는 에스테르화 된 카르복실 그룹이고, R1은 선택적으로 치환되는 알킬, 알케닐, 알릴, 알알킬, 헤테로 알알킬 그룹이며, R2는 선택적으로 치환되는 페닐 에틸, 페닐프로필, 또는 페닐 부틸 그룹이고, R3는 수소원자 또는 알킬 그룹이며, R4는 수소원자 또는 알킬 그룹이고, R5는 하나 또는 그 이상의 -O- 또는 -S- 원자 또는 -N(R7)- 그룹들[여기서 R7은 수소원자 또는 C1-6알킬그룹]에 의해 선택적으로 치환되는 알킬 또는 알케닐 그룹이며, X는 아미노(-NH2), 또는 치환된 아미노, 히드록실 또는 치환된 히드록실 그룹이다.
- 제1항에 있어서, R은 -CONHOH 또는 카르복실 (-CO2H) 그룹임을 특징으로 하는 화합물.
- 제1항 또는 제2항에 있어서, R1, R3와 R4가 각각 수소원자 임을 특징으로 하는 화합물.
- 제1-3항 중의 어느 한 항에 있어서, R2는 선택적으로 치환된는 페닐프로필 그룹임을 특징으로 하는 화합물.
- 상술된 항 중의 어느 한 항에 있어서, X는 아미노 또는 치환된 아미노 그룹임을 특징으로 하는 화합물.
- 식(Ia)의 화합물과 이의 염, 용매화합물 및 수화물.여기서 R은 -CONHOH, 카르복실(-CO2H) 또는 에스테르화 된 카르복실 그룹이고, R2는 선택적으로 치환되는 페닐프로필 그룹이며, R5는 하나 또는 그 이상의 -O- 또는 -S- 원자들 또는 -N(R7)-그룹 [여기서 R7은 수소원자 또는 C1-6알킬그룹]에 의해 선택적으로 억제되는, 선택적으로 치환되는 알킬 또는 알케닐 그룹이고, X는 아미노(-NH2) 또는 치환된 아미노, 히드록실 또는 치환된 히드록실 그룹이다.
- 제1 내지 6항 중의 어느 한 항에 따르는 화합물과 약학적으로 받아들여질 수 있는 희석제, 담체나 또는 부형제를 포함하는 약학적 조성물.
- 하기 (a), (b), (c)를 포함하는, 1항에 설명된 식(I)의 화합물의 제조방법, (a)식(II) 산 또는 이의 활성인 그리고/또는 보호된 유도체들은 식(III) 아민 또는 이의 보호된 유도체와 결합시키고 보호그룹을 제거하거나,또는 (b)식(IX)의 화합물을 탈카르복실화시켜 R이 -CO2H기인 식(I)의 화합물을 만들고/또는 (c)식(I)의 화합물을 상호전이(interconverting)시킨다.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9026251.0 | 1990-12-03 | ||
GB909026251A GB9026251D0 (en) | 1990-12-03 | 1990-12-03 | Netalloproteinase inhibitors |
GB919110338A GB9110338D0 (en) | 1991-05-13 | 1991-05-13 | Metalloproteinase inhibitors |
GB9110338.2 | 1991-05-13 | ||
GB9110339.0 | 1991-05-13 | ||
GB919110339A GB9110339D0 (en) | 1991-05-13 | 1991-05-13 | Metalloproteinase inhibitors |
GB9112901.5 | 1991-06-14 | ||
GB919112901A GB9112901D0 (en) | 1991-06-14 | 1991-06-14 | Metalloproteinase inhibitors |
GB919112888A GB9112888D0 (en) | 1991-06-14 | 1991-06-14 | Metalloproteinase inhibitors |
GB9112888.4 | 1991-06-14 | ||
GB919115039A GB9115039D0 (en) | 1991-07-11 | 1991-07-11 | Metalloproteinase inhibitors |
GB9115039.1 | 1991-07-11 | ||
GB919115038A GB9115038D0 (en) | 1991-07-11 | 1991-07-11 | Metalloproteinase inhibitors |
GB9115038.3 | 1991-07-11 | ||
GB919115916A GB9115916D0 (en) | 1991-07-23 | 1991-07-23 | Metalloproteinase inhibitors |
GB9115916.0 | 1991-07-23 | ||
PCT/GB1991/002142 WO1992009564A1 (en) | 1990-12-03 | 1991-12-03 | Peptidyl derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
KR927003520A true KR927003520A (ko) | 1992-12-18 |
Family
ID=27571285
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019920701787A KR927003520A (ko) | 1990-12-03 | 1991-12-03 | 펩티딜(peptidyl) 유도체 |
KR1019920701788A KR927003521A (ko) | 1990-12-03 | 1991-12-03 | 펩티딜(peptidyl) 유도체 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019920701788A KR927003521A (ko) | 1990-12-03 | 1991-12-03 | 펩티딜(peptidyl) 유도체 |
Country Status (16)
Country | Link |
---|---|
US (1) | US5300501A (ko) |
EP (2) | EP0489577B1 (ko) |
JP (2) | JPH05503720A (ko) |
KR (2) | KR927003520A (ko) |
AT (2) | ATE120451T1 (ko) |
AU (2) | AU652793B2 (ko) |
CA (2) | CA2073513A1 (ko) |
DE (2) | DE69108529T2 (ko) |
DK (1) | DK0489579T3 (ko) |
ES (1) | ES2069833T3 (ko) |
FI (2) | FI923494A (ko) |
GB (2) | GB2255339B (ko) |
GR (1) | GR3015567T3 (ko) |
HU (3) | HUT62263A (ko) |
NO (2) | NO922967L (ko) |
WO (2) | WO1992009565A1 (ko) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5268384A (en) * | 1990-11-21 | 1993-12-07 | Galardy Richard E | Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
US5892112A (en) * | 1990-11-21 | 1999-04-06 | Glycomed Incorporated | Process for preparing synthetic matrix metalloprotease inhibitors |
US5189178A (en) * | 1990-11-21 | 1993-02-23 | Galardy Richard E | Matrix metalloprotease inhibitors |
EP0520573A1 (en) * | 1991-06-27 | 1992-12-30 | Glaxo Inc. | Cyclic imide derivatives |
DE69309047T2 (de) * | 1992-04-07 | 1997-09-11 | British Biotech Pharm | Hydroxamsäure enthaltende collagenase-inhibitoren und cytokinaktivitätsinhibitoren |
GB9211706D0 (en) * | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
GB9211707D0 (en) * | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
AU666727B2 (en) * | 1992-06-25 | 1996-02-22 | F. Hoffmann-La Roche Ag | Hydroxamic acid derivatives |
US5326760A (en) * | 1992-06-29 | 1994-07-05 | Glaxo, Inc. | Aminobutanoic acid compounds having metalloprotease inhibiting properties |
US5629343A (en) * | 1992-10-02 | 1997-05-13 | Merck & Co., Inc. | N-(mercaptoacyl) peptidyl derivatives as antidegenerative agents |
US6090785A (en) * | 1992-10-15 | 2000-07-18 | Merck & Co., Inc. | Substituted N-carboxyalkylpeptidyl derivatives as antidegenerative agents |
GB9223904D0 (en) * | 1992-11-13 | 1993-01-06 | British Bio Technology | Inhibition of cytokine production |
JPH08503475A (ja) * | 1992-11-25 | 1996-04-16 | メルク エンド カンパニー インコーポレーテッド | 抗変性活性剤としてのカルボキシ−ペプチジル誘導体 |
US5646167A (en) * | 1993-01-06 | 1997-07-08 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamix acids |
US5552419A (en) * | 1993-01-06 | 1996-09-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
US5506242A (en) * | 1993-01-06 | 1996-04-09 | Ciba-Geigy Corporation | Arylsufonamido-substituted hydroxamic acids |
US5455258A (en) * | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
GB2290543B (en) * | 1993-03-16 | 1996-05-22 | British Biotech Pharm | Hydroxamic acid derivatives as metalloproteinase inhibitors |
WO1994022309A1 (en) * | 1993-04-07 | 1994-10-13 | Glycomed Incorporated | Synthetic matrix metalloprotease inhibitors and uses thereof |
GB9307956D0 (en) * | 1993-04-17 | 1993-06-02 | Walls Alan J | Hydroxamic acid derivatives |
GB9308695D0 (en) * | 1993-04-27 | 1993-06-09 | Celltech Ltd | Peptidyl derivatives |
AU6575394A (en) * | 1993-04-27 | 1994-11-21 | Celltech Therapeutics Limited | Peptidyl derivatives as metalloproteinase inhibitors |
AU7270794A (en) * | 1993-08-02 | 1995-02-28 | Celltech Limited | Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors |
US5594106A (en) * | 1993-08-23 | 1997-01-14 | Immunex Corporation | Inhibitors of TNF-α secretion |
GB9320660D0 (en) * | 1993-10-07 | 1993-11-24 | British Bio Technology | Inhibition of cytokine production |
US6037472A (en) * | 1993-11-04 | 2000-03-14 | Syntex (U.S.A.) Inc. | Matrix metalloprotease inhibitors |
DE69515702T2 (de) * | 1994-01-20 | 2000-08-10 | British Biotech Pharmaceuticals Ltd., Cowley | L-Tertiär-leucin-2-pyridylamid |
US5514716A (en) * | 1994-02-25 | 1996-05-07 | Sterling Winthrop, Inc. | Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof |
GB9501737D0 (en) * | 1994-04-25 | 1995-03-22 | Hoffmann La Roche | Hydroxamic acid derivatives |
WO1995032944A1 (en) * | 1994-05-28 | 1995-12-07 | British Biotech Pharmaceuticals Limited | Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors |
GB9411088D0 (en) * | 1994-06-03 | 1994-07-27 | Hoffmann La Roche | Hydroxylamine derivatives |
JPH10507158A (ja) * | 1994-06-22 | 1998-07-14 | ブリティッシュ バイオテック ファーマシューティカルズ リミテッド | 金属タンパク質分解酵素阻害剤 |
US5831004A (en) | 1994-10-27 | 1998-11-03 | Affymax Technologies N.V. | Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use |
US5840698A (en) * | 1994-10-27 | 1998-11-24 | Affymax Technologies N.V. | Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use |
GB9423914D0 (en) * | 1994-11-26 | 1995-01-11 | British Biotech Pharm | Polyether derivatives as metalloproteinase inhibitors |
US5919940A (en) * | 1995-01-20 | 1999-07-06 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
US5857961A (en) * | 1995-06-07 | 1999-01-12 | Clarus Medical Systems, Inc. | Surgical instrument for use with a viewing system |
US5917090A (en) * | 1995-06-30 | 1999-06-29 | British Biotech Pharmaceuticals Ltd. | Matrix metalloproteinase inhibitors |
IT1277904B1 (it) * | 1995-08-07 | 1997-11-12 | Polifarma Spa | Metodo per determinare l'attivita' terapeutica di composti inibitori di metalloproteinasi, nuovi composti inibitori, e loro impiego |
US5665777A (en) * | 1995-11-14 | 1997-09-09 | Abbott Laboratories | Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
NZ322553A (en) | 1995-11-23 | 1998-12-23 | British Biotech Pharm | Metalloproteinase inhibitors |
ATE283264T1 (de) * | 1995-12-08 | 2004-12-15 | Agouron Pharma | Zwischenprodukte zur herstellung von metallproteinasehemmern |
US6500948B1 (en) | 1995-12-08 | 2002-12-31 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof |
GB9613547D0 (en) * | 1996-06-27 | 1996-08-28 | Pharmacia Spa | Matrix metalloproteinase inhibitors |
US6462023B1 (en) | 1996-09-10 | 2002-10-08 | British Biotech Pharmaceuticals, Ltd. | Cytostatic agents |
EP0925278B1 (en) | 1996-09-10 | 2002-07-17 | British Biotech Pharmaceuticals Limited | Cytostatic hydroxamic acid derivatives |
US6953788B1 (en) | 1996-09-19 | 2005-10-11 | Aventis Pharmaceuticals Inc. | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
US6174915B1 (en) | 1997-03-25 | 2001-01-16 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
US6008243A (en) * | 1996-10-24 | 1999-12-28 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use |
JPH10130217A (ja) * | 1996-11-01 | 1998-05-19 | Kotobuki Seiyaku Kk | カルボン酸及びその誘導体及びその製造法並びにこれを含有する医薬組成物 |
US5952320A (en) * | 1997-01-07 | 1999-09-14 | Abbott Laboratories | Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion |
US5985911A (en) * | 1997-01-07 | 1999-11-16 | Abbott Laboratories | C-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretion |
ZA9818B (en) * | 1997-01-07 | 1998-07-02 | Abbott Lab | C-terminal ketone inhibitors of matrix metalloproteinases and tnf alpha secretion |
US5985900A (en) * | 1997-04-01 | 1999-11-16 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
EP0887077A1 (de) * | 1997-06-27 | 1998-12-30 | Roche Diagnostics GmbH | Verwendung von Azulenderivaten als Metalloproteaseinhibitoren |
GB9803005D0 (en) | 1998-02-12 | 1998-04-08 | British Biotech Pharm | Anti-inflammatory agents |
GB9804504D0 (en) * | 1998-03-03 | 1998-04-29 | Leo Pharm Prod Ltd | Matrix metalloproteinase inhibitors |
US6288261B1 (en) | 1998-12-18 | 2001-09-11 | Abbott Laboratories | Inhibitors of matrix metalloproteinases |
JP2001031637A (ja) * | 1999-05-17 | 2001-02-06 | Fuji Chemical Industries Ltd | 新規なヒドロキサム酸誘導体 |
CN1353689A (zh) * | 1999-05-17 | 2002-06-12 | 第一精密化学株式会社 | 新的异羟肟酸衍生物 |
CO5210860A1 (es) | 1999-10-01 | 2002-10-30 | Hoffmann La Roche | Nuevos derivados de pirimidina-2,4,6-triona |
US6797820B2 (en) | 1999-12-17 | 2004-09-28 | Vicuron Pharmaceuticals Inc. | Succinate compounds, compositions and methods of use and preparation |
WO2002006227A1 (fr) * | 2000-07-18 | 2002-01-24 | Chugai Seiyaku Kabushiki Kaisha | Inhibiteurs de la metalloprotease matricielle |
US6716845B2 (en) | 2001-03-30 | 2004-04-06 | Hoffmann-La Roche Inc. | Barbituric acid derivatives |
DE60219630T2 (de) | 2001-06-15 | 2007-12-27 | Vicuron Pharmaceuticals, Inc., Fremont | Bicyclische pyrrolidinverbindungen |
AR036053A1 (es) | 2001-06-15 | 2004-08-04 | Versicor Inc | Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas |
WO2005090387A2 (en) * | 2004-03-23 | 2005-09-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Histone h2a peptide derivatives and analogs and methods of use thereof |
US7605132B2 (en) * | 2001-08-29 | 2009-10-20 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Protective factors against inflammation, burns and noxious stimuli |
US7528227B2 (en) | 2004-03-23 | 2009-05-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Histone H2A peptide derivatives and uses thereof |
CN1732023A (zh) * | 2002-12-27 | 2006-02-08 | 血管技术国际股份公司 | 组合物和使用collajolie的方法 |
GB0818907D0 (en) * | 2008-10-15 | 2008-11-19 | Isis Innovation | Histone lysine demethylase inhibitors |
EP3061460A1 (en) | 2009-04-10 | 2016-08-31 | Tufts Medical Center, Inc. | Par-1 activation by metalloproteinase-1 (mmp-1) |
DE102014206916A1 (de) | 2014-04-10 | 2015-10-15 | Wacker Chemie Ag | Verfahren zur Ruthenium-katalysierten Umvinylierung von Carbonsäuren |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4743587A (en) * | 1985-09-10 | 1988-05-10 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
FR2609289B1 (fr) * | 1987-01-06 | 1991-03-29 | Bellon Labor Sa Roger | Nouveaux composes a activite d'inhibiteurs de collagenase, procede pour les preparer et compositions pharmaceutiques contenant ces composes |
GB8827308D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
GB8827305D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
CA2058797A1 (en) * | 1991-02-01 | 1992-08-02 | Michael John Broadhurst | Amino acid derivatives |
US5196412A (en) * | 1991-03-06 | 1993-03-23 | Johnson Matthey, Inc. | Gallium compounds |
-
1991
- 1991-12-03 KR KR1019920701787A patent/KR927003520A/ko not_active Application Discontinuation
- 1991-12-03 ES ES91311254T patent/ES2069833T3/es not_active Expired - Lifetime
- 1991-12-03 DE DE69108529T patent/DE69108529T2/de not_active Expired - Fee Related
- 1991-12-03 EP EP91311252A patent/EP0489577B1/en not_active Expired - Lifetime
- 1991-12-03 HU HU922497A patent/HUT62263A/hu unknown
- 1991-12-03 AT AT91311254T patent/ATE120451T1/de not_active IP Right Cessation
- 1991-12-03 WO PCT/GB1991/002143 patent/WO1992009565A1/en active Application Filing
- 1991-12-03 KR KR1019920701788A patent/KR927003521A/ko not_active Application Discontinuation
- 1991-12-03 DK DK91311254.6T patent/DK0489579T3/da active
- 1991-12-03 HU HU9202498A patent/HUT61973A/hu unknown
- 1991-12-03 CA CA002073513A patent/CA2073513A1/en not_active Abandoned
- 1991-12-03 HU HU922497Q patent/HU9202497D0/hu unknown
- 1991-12-03 EP EP91311254A patent/EP0489579B1/en not_active Expired - Lifetime
- 1991-12-03 AU AU90173/91A patent/AU652793B2/en not_active Ceased
- 1991-12-03 US US07/916,108 patent/US5300501A/en not_active Expired - Lifetime
- 1991-12-03 JP JP4500489A patent/JPH05503720A/ja active Pending
- 1991-12-03 AU AU90233/91A patent/AU652596B2/en not_active Ceased
- 1991-12-03 AT AT91311252T patent/ATE120182T1/de active
- 1991-12-03 WO PCT/GB1991/002142 patent/WO1992009564A1/en active Application Filing
- 1991-12-03 JP JP4500488A patent/JPH05503719A/ja active Pending
- 1991-12-03 DE DE69108363T patent/DE69108363T2/de not_active Expired - Fee Related
- 1991-12-03 CA CA002073510A patent/CA2073510A1/en not_active Abandoned
-
1992
- 1992-06-02 GB GB9211714A patent/GB2255339B/en not_active Expired - Fee Related
- 1992-06-02 GB GB9211715A patent/GB2255340B/en not_active Expired - Fee Related
- 1992-07-28 NO NO92922967A patent/NO922967L/no unknown
- 1992-07-28 NO NO92922968A patent/NO922968L/no unknown
- 1992-08-03 FI FI923494A patent/FI923494A/fi not_active Application Discontinuation
- 1992-08-03 FI FI923495A patent/FI923495A/fi not_active Application Discontinuation
-
1995
- 1995-03-30 GR GR940403917T patent/GR3015567T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR927003520A (ko) | 펩티딜(peptidyl) 유도체 | |
DE68916071D1 (de) | 3-Pyrrolidinylthio-1-azabicyclo (3.2.0)hept-2-en-2-carbonsäure-Verbindungen. | |
EA200300792A1 (ru) | Хиназолины в качестве ингибиторов ммр-13 | |
ATE255579T1 (de) | Pyrrolidin-derivate die eine phospholipase-a2- hemmende wirkung haben | |
DE68917023D1 (de) | 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen. | |
DE3372707D1 (en) | Spiro-(4,(3+n))-2-aza-alkan-3-carboxylic-acid derivatives, process for their preparation,agents containing them and their use | |
ATE129241T1 (de) | Derivate von 1-naphthylpiperazin, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
KR890013044A (ko) | Pt(IV)착화합물 | |
DE69011569D1 (de) | Verbindungen der 1-Azabicyclo(3.2.0)hept-2-en-2-carbonsäure. | |
ES488656A1 (es) | Procedimiento para la preparacion de derivados de acidos aziridin-2-carboxilicos substituidos en n | |
KR900014388A (ko) | 에세롤린의 카보네이트 유도체, 이의 제조방법 및 약제로서의 용도 | |
GB1212460A (en) | Naphthacene derivatives | |
KR900001715A (ko) | Bu-3608 유도체 | |
KR910000133A (ko) | 아민 | |
EA200001107A1 (ru) | ПРОИЗВОДНЫЕ ОКТАГИДРО-6,10-ДИОКСО-6H-ПИРИДАЗИНО [1,2-a] [1,2] ДИАЗЕПИН-1-КАРБОНОВОЙ КИСЛОТЫ, СПОСОБ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ТЕРАПЕВТИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ | |
EA200000374A2 (ru) | Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции | |
CA2280395A1 (fr) | Nouveaux derives d'acide hydroxamique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
RU2004130283A (ru) | Комбинации, включающие производные эпотилона и алкилирующие агенты | |
DK0452809T3 (da) | Terapautisk middel til pollakisuri, urgeinkontinens eller urininkontinens omfattende alfa-phenyl-alfa-pyridylalkansyrederivater | |
KR960031439A (ko) | 치환 인돌 유도체 | |
RU94026088A (ru) | Способ лечения шока и способ ингибирования продуцирования альфа фактора некроза опухоли | |
SE8303718L (sv) | E-homo-enurnanderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande dessa foreningar | |
RU94043799A (ru) | Производные эпи-эпибатиденов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |